GOWEN MAXINE
Insider CIK 1280044 · TRVN President & CEO, Director · AKBA Director · ACRS Director · MRUS Director · PASG Director · IDRA Director · HGSI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-06-05 | 2026-06-08 | 11,580 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-06-05 | 2026-06-08 | 11,580 | — | $0 | 33,334 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 42,350 | — | $0 | 42,350 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 10,987 | — | $0 | 10,987 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 10,539 | — | $0 | 10,539 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 14,414 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 12,240 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 16,604 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 7,957 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,844 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 13,193 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-09 | 4,793 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-09 | 4,793 | — | $0 | 21,754 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 11,580 | — | $0 | 11,580 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 42,350 | — | $0 | 42,350 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 201,857 | — | $0 | 201,857 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2025-05-22 | 2025-05-27 | 13,193 | — | $0 | 13,193 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 4,793 | — | $0 | 4,793 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 16,961 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2024-05-21 | 2024-05-23 | 47,693 | — | $0 | 47,693 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2024-05-07 | 2024-05-09 | 8,844 | — | $0 | 8,844 | SEC↗ |
| ACGN Aceragen, Inc. | S Sale | 2023-08-10 | 2023-08-11 | 51 | $0.51 | $26 | 0 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2023-06-08 | 2023-06-12 | 14,414 | — | $0 | 14,414 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 12,301 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 4,660 | — | $0 | 4,660 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2023-05-25 | 2023-05-26 | 24,000 | — | $0 | 24,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-06-23 | 2022-06-27 | 26,000 | — | $0 | 26,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 7,794 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 4,507 | — | $0 | 4,507 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2022-05-31 | 2022-06-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2022-05-31 | 2022-06-02 | 16,604 | — | $0 | 16,604 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 24,000 | — | $0 | 24,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-06-08 | 2021-06-10 | 26,000 | — | $0 | 26,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 12,250 | — | $0 | 12,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 3,356 | — | $0 | 3,356 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2021-05-28 | 2021-06-02 | 12,240 | — | $0 | 12,240 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2021-05-28 | 2021-06-16 | 12,240 | — | $0 | 12,240 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2021-05-27 | 2021-06-01 | 4,542 | — | $0 | 4,542 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2021-02-18 | 2021-02-22 | 33,836 | — | $0 | 33,836 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2020-06-08 | 2020-06-09 | 4,567 | $12.05 | $55.0K | 24,133 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-06-05 | 2020-06-09 | 13,700 | — | $0 | 28,700 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 16,500 | — | $0 | 16,500 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2020-05-13 | 2020-05-15 | 64,103 | — | $0 | 64,103 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2020-05-12 | 2020-05-19 | 11,500 | — | $0 | 11,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 4,438 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 4,438 | — | $0 | 4,438 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 4,438 | — | $0 | 4,438 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-07-02 | 2019-07-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-06-06 | 2019-06-10 | 13,700 | — | $0 | 15,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2019-06-04 | 2019-06-06 | 11,500 | — | $0 | 11,500 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2019-05-16 | 2019-05-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2019-02-01 | 2019-02-05 | 50,000 | $1.02 | $51.0K | 54,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2018-06-20 | 2018-06-22 | 50,000 | $1.53 | $76.5K | 50,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-06-14 | 2018-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2018-02-28 | 2018-03-02 | 252,500 | — | $0 | 252,500 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2018-02-28 | 2018-03-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2017-08-28 | 2017-08-29 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2017-06-07 | 2017-06-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-05-25 | 2017-06-09 | 403 | — | $0 | 195,512 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-05-25 | 2017-06-09 | 403 | — | $0 | 4,000 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-03-16 | 2017-06-09 | 60,000 | — | $0 | 216,500 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-03-16 | 2017-06-09 | 60,000 | — | $0 | 4,403 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-03-13 | 2017-06-09 | 50,000 | — | $0 | 195,109 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-03-13 | 2017-06-09 | 50,000 | — | $0 | 64,403 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2017-03-02 | 2017-03-03 | 303,000 | — | $0 | 303,000 | SEC↗ |
| TRVN TREVENA INC | M Exercise deriv | 2017-02-23 | 2017-02-27 | 106,329 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | M Exercise deriv | 2017-02-23 | 2017-02-27 | 4,074 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | M Exercise | 2017-02-23 | 2017-02-27 | 110,403 | $0.68 | $75.1K | 126,903 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-01-23 | 2017-06-09 | 6,000 | — | $0 | 114,403 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-01-23 | 2017-06-09 | 6,000 | — | $0 | 145,109 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-01-23 | 2017-06-09 | 6,500 | — | $0 | 156,500 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-01-23 | 2017-06-09 | 6,500 | — | $0 | 120,403 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-01-06 | 2017-06-09 | 150,000 | — | $0 | 4,000 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2017-01-06 | 2017-06-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2017-01-06 | 2017-01-06 | 175,000 | — | $0 | 175,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2017-01-04 | 2017-01-05 | 7,000 | $1.50 | $10.5K | 17,543 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2016-11-07 | 2016-11-09 | 12,500 | $4.10 | $51.2K | 16,500 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-10-20 | 2016-10-25 | 4,084 | — | $0 | 139,109 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-10-20 | 2016-10-25 | 10,000 | — | $0 | 8,084 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-10-20 | 2016-10-25 | 10,000 | — | $0 | 154,000 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-10-20 | 2016-10-25 | 4,084 | — | $0 | 4,000 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-10-17 | 2016-10-19 | 135,025 | — | $0 | 28,084 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-10-17 | 2016-10-19 | 10,000 | — | $0 | 18,084 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-10-17 | 2016-10-19 | 135,025 | — | $0 | 135,025 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-10-17 | 2016-10-19 | 10,000 | — | $0 | 144,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2016-10-03 | 2016-10-05 | 4,102 | $2.56 | $10.5K | 10,543 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-09-29 | 2016-10-19 | 130,000 | — | $0 | 134,000 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2016-09-29 | 2016-10-19 | 130,000 | — | $0 | 163,109 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2016-07-01 | 2016-07-06 | 6,441 | $1.63 | $10.5K | 6,441 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2016-06-16 | 2016-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2016-06-13 | 2016-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2016-05-27 | 2016-05-31 | 14,084 | $7.08 | $99.7K | 293,109 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2016-05-26 | 2016-05-31 | 4,000 | $7.20 | $28.8K | 4,000 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2016-05-26 | 2016-05-31 | 4,000 | $7.19 | $28.8K | 279,025 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 350,000 | — | $0 | 350,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2016-01-04 | 2016-01-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2015-06-10 | 2015-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2015-03-17 | 2015-03-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| TRVN TREVENA INC | G Gift | 2015-02-20 | 2015-03-19 | 51,000 | — | $0 | 275,025 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-12-10 | 2014-12-10 | 8,000 | $4.00 | $32.0K | 326,025 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-13 | 2014-11-14 | 1,300 | $11.82 | $15.4K | 1,300 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2014-07-28 | 2014-08-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TRVN TREVENA INC | M Exercise deriv | 2014-04-23 | 2014-05-15 | 124,477 | — | $0 | 106,329 | SEC↗ |
| TRVN TREVENA INC | M Exercise | 2014-04-23 | 2014-05-15 | 124,477 | $0.68 | $84.6K | 318,025 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2014-02-20 | 2014-03-11 | 175,000 | — | $0 | 175,000 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 25,000 | $14.25 | $356.3K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer | 2012-07-30 | 2012-08-01 | 4,166 | $14.25 | $59.4K | 24,497 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | U Tender | 2012-07-30 | 2012-08-01 | 11,320 | $14.25 | $161.3K | 13,177 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer | 2012-07-30 | 2012-08-01 | 13,177 | $14.25 | $187.8K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award deriv | 2012-05-17 | 2012-05-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award | 2012-05-17 | 2012-05-21 | 2,500 | — | $0 | 28,663 | SEC↗ |